Interleukin-17 targeted therapies in axial spondyloarthritis

Affiliation auteurs!!!! Error affiliation !!!!
TitreInterleukin-17 targeted therapies in axial spondyloarthritis
Type de publicationJournal Article
Year of Publication2015
AuteursWendling D
JournalIMMUNOTHERAPY
Volume7
Pagination1125-1128
Type of ArticleEditorial Material
ISSN1750-743X
Mots-clésankylosing spondylitis, IL-17, IL-23, Secukinumab, Spondyloarthritis, treatment, Ustekinumab
Résumé

``...targeting IL-23/IL-17 is a promising and potentially fruitful way for the future of axial spondyloarthritis treatment.''

DOI10.2217/imt.15.85